Stay updated on KarXT for Alzheimer's Psychosis Clinical Trial
Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.

Latest updates to the KarXT for Alzheimer's Psychosis Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedUpdated the study record to add sponsor details (Karuna Therapeutics, Inc.), update primary and secondary objectives, include EU CTR and other IDs, and expand site contacts and investigators. Added IPD sharing information and links to the protocol, SAP, CSR, and related documents.SummaryDifference4%

- Check17 days agoChange DetectedPage revision updated to v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check24 days agoChange Detected- Removed the sponsor line "Karuna Therapeutics, Inc., a Bristol Myers Squibb company" and the "Collaborators" section from the Study Details page.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded Djamchid Lotfi (Site 1004) as the study contact with phone 713-484-6947 and included Karuna Therapeutics as Collaborator; Nelson Berrios (Site 1004) was removed.SummaryDifference0.2%

- Check53 days agoChange DetectedRevision tag updated to v3.4.2, replacing the previous v3.4.1. This appears to be a routine maintenance update with no impact on study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to KarXT for Alzheimer's Psychosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis Clinical Trial page.